Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Summit Nuclear — Predicate Candidate Screening
6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
139 daysmedian FDA review time
171 days90th percentile
6clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K935273 | VISION FX 40 & 80 SERIES GAMMA CAMERA | Summit Nuclear | 1994-04-18 | 167 | 2 |
| K935318 | SUMMIT NUCLEAR VISION FX 20 SERIES GAMMA CAMERA SYSTEMS | Summit Nuclear | 1994-02-25 | 113 | 0 |
| K922427 | SUMMIT NUCLEAR VISION 1024RZ GAMMA CAMERA SYSTEM | Summit Nuclear | 1992-09-29 | 130 | 0 |
| K922426 | SUMMIT NUCLEAR VISION T-22 GAMMA CAMERA SYSTEM | Summit Nuclear | 1992-09-28 | 129 | 0 |
| K920958 | SUMMIT NUCLEAR VISION NEUROSPECT | Summit Nuclear | 1992-08-07 | 171 | 0 |
| K912573 | VISION (NUCLEAR MEDICINE COMPUTER) | Summit Nuclear | 1991-10-28 | 139 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda